The Challenge of Change - Managing Excipients Control
Colorcon
All news > Audio podcasts
PodCast news direct
All the breaking news across the pharmaceutical manufacturing and outsourcing sectors.
TFS and Siemens hope to have process analysis down PAT
US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production.
First USP OK for rHAs a "significant advantage", says Novozymes
Two recombinant human albumins made by Novozymes' biopharma division have become the first to comply with the USP-NF's recently revised excipient monograph.
Novartis comments on $490m cell-culture vaccine contract
Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman Matt Stober about the new plant.
Interview with IPEC China chairman Nevin Cheng
Since its inauguration last year, IPEC China has been working to improve the quality of excipient manufacturing in the country. in-PharmaTechnologist spoke with organisation president Nevin Cheng about the steps the body has taken so far and what it will be doing in 2009, including its plans for a new SFDA approved Drug Master File (DMF) scheme.
Latest podcast
All the breaking news across the pharmaceutical manufacturing and outsourcing sectors.
First podcast from in-PharmaTechnologist.com
Welcome to in-pharma technologist’s podcast. In the next three minutes Gareth Macdonald will take you through the top industry headlines this week. Product authenticity dominated the news, with US regulators announcing increased penalties for those convicted of selling dangerous counterfeits. In Europe IPEC sets out its new third party assessment scheme.
BIO 2009
in-PharmaTechnologist brings you audio interviews with industry leaders at BIO 2009, which took place in Atlanta, US and attracted delegations from around the globe.
BIO 2009: snapshot of an evolving biotech industry
in-Pharmatechnologist's Nick Taylor looks back on BIO 2009, an event at which uncertainty about the development of the biotechnology industry’s future shape dominated proceedings.
France helps clusters battle for bio bucks
HEM Pierre Vimont, Ambassador of France to the US, was at BIO 2009 talking about the measures his nation have taken to attract biotechs, including the introduction of the "most favourable R&D tax in Europe".
Interphex 2009
Fresh from a fascinating trip to Interphex 2009 in New York, in-PharmaTechnologist brings you interview with some of the drug, processing and packaging industry's leading players. Hear key industry perspectives on trends within the sector.
Packaging feeling effects of downturn, says Alcan pharmaceutical packaging president
Michael Schmitt, president of Alcan Global Pharmaceutical Packaging, believes a recovery in the global economy, the increasing demand for quality and the emergence of markets like India and Brazil will be key drivers for the packaging sector over the next few years.
Pharma Phacts
In-PharmaTechnologist's Pharma Phacts series brings you a 90 second micro-dose of the latest discoveries and science news affecting the pharmaceutical manufacturing, processing and packaging industries.
Nanotech polymer manufacture may help create better packaging
This week in-PharmaTechnologist's Pharma Phacts podcast focuses on a nanotechnology method that could produce more effective barrier packaging using less material.
Deuteration may help drug development
New research suggests that deuteration, the replacement of hydrogen atoms with heavier forms, can alter an API's crystallisation properties and help drugmakers make better more effective drugs.
AAPS 2008 podcasts
The American Association of Pharmaceutical Sientists (AAPS) meeting in Atlanta saw presentations and product launches from a wide range of firms operating in the outsourcing and drug manufacturing sectors.
Light microscopy technique for improving contaminant analysis
The timely identification of contaminants in pharmaceutical manufacture can be critical to avoiding costly delays. While it is relatively straightforward to establish the composition of a contaminating particle, determining its origin in the manufacturing process can be much more problematic. in-PharmaTechnologist spoke with McCrone Associates' Heidi Ullberg at this year's AAPS in Atlanta about a light microscopy that can help drugmakers address this problem.
AAPS preview
American Association of Pharmaceutical Scientist's (AAPS) president Dr Karen Habucky sets out the programme for the group's forthcoming annual meeting and exposition, which is being held in Atlanta, US between November 16- 20.
Spotlight
  EU plan to add APIs to pollutant watch list could raise costsEuropean Commission plans to add three APIs to its list of water polluting chemicals could result in... |
Supplier Webinars
On demand Supplier Webinars
All supplier webinars
Latest news
On your radar
Globalisation
- China healthcare spending up despite economic fears, BD says
- FDA calls for more powers to adopt nationwide ePedigree
Lifecycle management
- Samsung and Quintiles' biosimilars JV teams with Biogen Idec
- Ongoing quality problems at injectables plant hurt Hospira in Q3
Counterfeiting
- Annual WHO meeting to tackle spread of substandard drugs
- FDA calls for more powers to adopt nationwide ePedigree
